Fluorinated N, N -dialkylaminostilbenes for wnt pathway inhibition and colon cancer repression

Journal of Medicinal Chemistry

Volumn 54, Issue 5, 2011, Pages 1288-1297

  Zhang, Wen ^a,b   Sviripa, Vitaliy ^a   Kril, Liliia M ^a   Chen, Xi ^a,b   Yu, Tianxin ^a,b   Shi, Jiandang ^a,b   Rychahou, Piotr ^a,b   Evers, B Mark ^a,b   Watt, David S ^a   Liu, Chunming ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 (2 FLUOROSTYRYL)PHENYL] 4 METHYLPIPERAZINE; 2 (2,6 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 2 [4 (2 FLUOROSTYRYL)PHENYL] 1 METHYL 1H IMIDAZOLE; 3 (2,6 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (2 FLUOROSTYRYL) N,N DIETHYLANILINE; 4 (2 FLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (2 FLUOROSTYRYL) N,N DIMETHYLNAPHTHALEN 1 AMINE; 4 (2,3 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (2,4 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (2,5 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (2,6 DIFLUOROPHENETHYL) N,N DIMETHYLANILINE; 4 (2,6 DIFLUOROSTYRYL) N,N DIETHYLANILINE; 4 (2,6 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (3 FLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (3,4 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (3,5 DIFLUOROSTYRYL) N,N DIMETHYLANILINE; 4 (4 FLUOROSTYRYL) N,N DIMETHYLANILINE; 4 HYDROXYSTILBENE; 4 METHOXYSTILBENE; 4 STYRYL N,N DIMETHYLANILINE; BETA CATENIN; N,N DIALKYLAMINOSTILBENE DERIVATIVE; N,N DIMETHYL 4 (2,3,6 TRIFLUOROSTYRYL)ANILINE; N,N DIMETHYL 4 (2,4,6 TRIFLUOROSTYRYL)ANILINE; PTEROSTILBENE; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; COLORECTAL CANCER; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; STEREOISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS; WNT PROTEINS;

EID: 79952265332     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101248v     Document Type: Article

References (37)

1. Clevers, H. Wnt/beta-catenin signaling in development and disease Cell 2006, 127, 469-480
2. van Amerongen, R.; Nusse, R. Towards an integrated view of Wnt signaling in development Development 2009, 136, 3205-3214
3. Giles, R. H.; van Es, J. H.; Clevers, H. Caught up in a Wnt storm: Wnt signaling in cancer Biochim. Biophys. Acta 2003, 1653, 1-24 (Pubitemid 36627817)
4. Kinzler, K. W.; Vogelstein, B. Lessons from hereditary colorectal cancer Cell 1996, 87, 159-170 (Pubitemid 26358996)
5. Polakis, P. Wnt signaling and cancer Genes Dev. 2000, 14, 1837-1851 (Pubitemid 30639518)
6. Liu, C.; Kato, Y.; Zhang, Z.; Do, V. M.; Yankner, B. A.; He, X. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 6273-6278 (Pubitemid 29256655)
7. Liu, C.; Li, Y.; Semenov, M.; Han, C.; Baeg, G. H.; Tan, Y.; Zhang, Z.; Lin, X.; He, X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism Cell 2002, 108, 837-847 (Pubitemid 34327534)
8. Zeng, X.; Tamai, K.; Doble, B.; Li, S.; Huang, H.; Habas, R.; Okamura, H.; Woodgett, J.; He, X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation Nature 2005, 438, 873-877 (Pubitemid 41753071)
9. Zeng, X.; Huang, H.; Tamai, K.; Zhang, X.; Harada, Y.; Yokota, C.; Almeida, K.; Wang, J.; Doble, B.; Woodgett, J.; Wynshaw-Boris, A.; Hsieh, J. C.; He, X. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions Development 2008, 135, 367-375 (Pubitemid 351228428)
10. Yang, J.; Zhang, W.; Evans, P. M.; Chen, X.; He, X.; Liu, C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells J. Biol. Chem. 2006, 281, 17751-17757 (Pubitemid 44035574)
11. Huang, S. M.; Mishina, Y. M.; Liu, S.; Cheung, A.; Stegmeier, F.; Michaud, G. A.; Charlat, O.; Wiellette, E.; Zhang, Y.; Wiessner, S.; Hild, M.; Shi, X.; Wilson, C. J.; Mickanin, C.; Myer, V.; Fazal, A.; Tomlinson, R.; Serluca, F.; Shao, W.; Cheng, H.; Shultz, M.; Rau, C.; Schirle, M.; Schlegl, J.; Ghidelli, S.; Fawell, S.; Lu, C.; Curtis, D.; Kirschner, M. W.; Lengauer, C.; Finan, P. M.; Tallarico, J. A.; Bouwmeester, T.; Porter, J. A.; Bauer, A.; Cong, F. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 2009, 461, 614-620
12. Chen, B.; Dodge, M. E.; Tang, W.; Lu, J.; Ma, Z.; Fan, C. W.; Wei, S.; Hao, W.; Kilgore, J.; Williams, N. S.; Roth, M. G.; Amatruda, J. F.; Chen, C.; Lum, L. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer Nat. Chem. Biol. 2009, 5, 100-107
13. Liu, C.; He, X. Destruction of a destructor: a new avenue for cancer therapeutics targeting the Wnt pathway J. Mol. Cell Biol. 2010, 2, 70-73
14. Barker, N.; Clevers, H. Mining the Wnt pathway for cancer therapeutics Nat. Rev. Drug Discovery 2006, 5, 997-1014 (Pubitemid 44835127)
15. Garber, K. Drugging the Wnt pathway: problems and progress J. Natl. Cancer Inst. 2009, 101, 548-550
16. Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises J. Nutr. Biochem. 2005, 16, 449-466 (Pubitemid 41039220)
17. Athar, M.; Back, J. H.; Tang, X.; Kim, K. H.; Kopelovich, L.; Bickers, D. R.; Kim, A. L. Resveratrol: a review of preclinical studies for human cancer prevention Toxicol. Appl. Pharmacol. 2007, 224, 274-283 (Pubitemid 47575677)
18. Suh, N.; Paul, S.; Hao, X.; Simi, B.; Xiao, H.; Rimando, A. M.; Reddy, B. S. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats Clin. Cancer Res. 2007, 13, 350-355 (Pubitemid 46121889)
19. Vanamala, J.; Reddivari, L.; Radhakrishnan, S.; Tarver, C. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways BMC Cancer 2010, 10, 238
20. Roccaro, A. M.; Leleu, X.; Sacco, A.; Moreau, A. S.; Hatjiharissi, E.; Jia, X.; Xu, L.; Ciccarelli, B.; Patterson, C. J.; Ngo, H. T.; Russo, D.; Vacca, A.; Dammacco, F.; Anderson, K. C.; Ghobrial, I. M.; Treon, S. P. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia Clin. Cancer Res. 2008, 14, 1849-1858 (Pubitemid 351469472)
21. Hope, C.; Planutis, K.; Planutiene, M.; Moyer, M. P.; Johal, K. S.; Woo, J.; Santoso, C.; Hanson, J. A.; Holcombe, R. F. Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer prevention Mol. Nutr. Food Res. 2008, 52 (Suppl. 1) S52-S61
22. Pecere, T.; Gazzola, M. V.; Mucignat, C.; Parolin, C.; Vecchia, F. D.; Cavaggioni, A.; Basso, G.; Diaspro, A.; Salvato, B.; Carli, M.; Palu, G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors Cancer Res. 2000, 60, 2800-2804 (Pubitemid 30395795)
23. Chiang, Y. J.; Hsiao, S. J.; Yver, D.; Cushman, S. W.; Tessarollo, L.; Smith, S.; Hodes, R. J. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development PLoS One 2008, 3, e2639
24. Choi, H. Y.; Lim, J. E.; Hong, J. H. Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells Prostate Cancer Prostatic Dis. 2010, 13, 343-349
25. Kim, J.; Zhang, X.; Rieger-Christ, K. M.; Summerhayes, I. C.; Wazer, D. E.; Paulson, K. E.; Yee, A. S. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1 J. Biol. Chem. 2006, 281, 10865-10875 (Pubitemid 43855509)
26. Leow, P. C.; Tian, Q.; Ong, Z. Y.; Yang, Z.; Ee, P. L. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells Invest. New Drugs 2010, 28, 766-782
27. Paul, S.; DeCastro, A. J.; Lee, H. J.; Smolarek, A. K.; So, J. Y.; Simi, B.; Wang, C. X.; Zhou, R.; Rimando, A. M.; Suh, N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats Carcinogenesis 2010, 31, 1272-1278
28. Zhou, H.; Shang, L.; Li, X.; Zhang, X.; Gao, G.; Guo, C.; Chen, B.; Liu, Q.; Gong, Y.; Shao, C. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells Exp. Cell Res. 2009, 315, 2953-2962
29. Wang, H.; Zhou, H.; Zou, Y.; Liu, Q.; Guo, C.; Gao, G.; Shao, C.; Gong, Y. Resveratrol modulates angiogenesis through the GSK3beta/beta-catenin/TCF- dependent pathway in human endothelial cells Biochem. Pharmacol. 2010, 80, 1386-1395
30. Barker, N.; van Es, J. H.; Kuipers, J.; Kujala, P.; van den Born, M.; Cozijnsen, M.; Haegebarth, A.; Korving, J.; Begthel, H.; Peters, P. J.; Clevers, H. Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 2007, 449, 1003-1007 (Pubitemid 350014593)
31. Henry, C.; Vitrac, X.; Decendit, A.; Ennamany, R.; Krisa, S.; Merillon, J. M. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells J. Agric. Food Chem. 2005, 53, 798-803 (Pubitemid 40194406)
32. Gu, B.; Watanabe, K.; Dai, X. Epithelial stem cells: an epigenetic and Wnt-centric perspective J. Cell. Biochem. 2010, 110, 1279-1287
33. Saegusa, M.; Hashimura, M.; Kuwata, T.; Hamano, M.; Okayasu, I. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells Lab. Invest. 2005, 85, 768-779 (Pubitemid 40799706)
34. Narender, T.; Papi Reddy, K.; Madhur., G. Synthesis of (E)-stilbenes and (E, E)-1,4-diphenylbuta-1,3-diene promoted by boron trifluoride-diethyl ether complex Synthesis 2009, 22, 3791-3796
35. 18F)-fluorobenzaldehyde using the Horner-Wadsworth-Emmons reaction J. Labelled Compd. Radiopharm. 2007, 50, 105-113
36. Moran, B. W.; Anderson, F. P.; Devery, A.; Cloonan, S.; Butler, W. E.; Varughese, S.; Draper, S. M.; Kenny, P. T. Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol Bioorg. Med. Chem. 2009, 17, 4510-4522
37. Zhang, W.; Chen, X.; Kato, Y.; Evans, P. M.; Yuan, S.; Yang, J.; Rychahou, P. G.; Yang, V. W.; He, X.; Evers, B. M.; Liu, C. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression Mol. Cell. Biol. 2006, 26, 2055-2064 (Pubitemid 43346910)